Aortic Valve Myxoma Presenting with a Stroke: A case report and review of the literature by Alkuwaiti, Feras A. et al.
Departments of 2Surgery and 3Internal Medicine, 1College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
*Corresponding Author’s e-mail: feras_a_k@yahoo.com
ورم خماطي يف الصمام األهبري يعرض كسكتة دماغية
تقرير حالة و مراجعة لألدبيات الطبية
فرا�س اأحمد الكويتي، يا�رص الغنيمي، �شامي غزال
abstract: Myxomas originating from the aortic valve are rare. We report a 40-year-old male patient who 
presented to the King Fahd Hospital of the University, Khobar, Saudi Arabia, in 2017 with a stroke. Transoesophageal 
echocardiography indicated a mobile mass measuring 6 × 2 mm attached to the right coronary cusp of the aortic 
valve and a mobile interatrial septum with a small patent foramen ovale (PFO). The patient underwent surgical 
excision of the mass and direct closure of the PFO. Histopathology confirmed the mass to be a myxoma. Despite 
their rarity, the recognition and treatment of valvular myxomas is very important; moreover, clinicians should be 
aware that affected patients may present with an embolic stroke.
Keywords: Aortic Valve; Myxoma; Patent Foramen Ovale; Stroke; Transesophageal Echocardiography; Case Report; 
Saudi Arabia.
امللخ�ص: يعد الورم املخاطي النا�شئ عن �شمامات القلب حالة نادرة احلدوث. نعر�س هنا حالة مري�س رجل يبلغ من العمر 40 عاًما تقدم 
اإىل م�شت�شفى امللك فهد اجلامعي، اخُلرب، اململكة العربية ال�شعودية، يف عام 2017 ب�شكتة دماغية. اأ�شار تخطيط �شدى القلب عرب املريء 
اإىل وجود كتلة متحركة بحجم 2 × 6 مم مت�شلة بال�رصفة التاجية اليمنى لل�شمام الأبهري واحلاجز الأذيني مع وجود ثقب بي�شاوي قلبي 
�شغري. خ�شع املري�س لالإ�شتئ�شال اجلراحي واإغالق مبا�رص للثقب البي�شاوي القلبي. اأكد تقرير مر�شيات الأن�شجة على اأن الكتلة هي عبارة 
عن ورم خماطي. على الرغم من ندرة احلالة، اإل اأن معرفة وعالج  الورم احلبيبي لل�شمامات يعترب مهمة للغاية؛ عالوة على ذلك، يجب اأن 
يكون الأطباء على دراية باأن املر�شى امل�شابني قد يظهرون ب�شكتة دماغية �شمّية.
اململكة  القلب عرب املريء؛ تقرير حالة؛  الدماغية؛ تخطيط �شدى  ال�شكتة  القلبي؛  البي�شاوي  الثقب  الأبهري؛ ورم خماطي؛  ال�شمام  املفتاحية:  الكلمات 
العربية ال�شعودية.
Aortic Valve Myxoma Presenting with a Stroke
A case report and review of the literature
*Feras A. Alkuwaiti,1 Yasser Elghoneimy,2 Sami Ghazal3
Sultan Qaboos University Med J, November 2018, Vol. 18, Iss. 4, pp. e537–540, Epub. 28 Mar 19
Submitted 27 May 18
Revision Req. 26 Jun 18; Revision Recd. 25 Jul 18
Accepted 9 Aug 18
case report
doi: 10.18295/squmj.2018.18.04.019
Myxomas originating from the cardiacvalves are uncommon.1,2 These benign tumours typically occur between the fourth and seventh 
decades of life and usually affect women more comm-
only than men.1 The condition is mostly sporadic in 
nature, but can also be familial.2 Myxomas are true neo- 
plasms in that they are derived from primitive multipotent 
mesenchymal cells which may exist as embryonic rem- 
nants in the heart wall.3
Rarely, myxomas may arise from both the ventr-
icular aspect and the margin of the aortic valve cusps; 
moreover, one or both leaflets may also be affected.4 
Although transoesophageal echocardiography (TEE) 
aids in the assessment of such masses, histopathology 
is considered the gold-standard method to confirm a 
diagnosis.4,5 This report describes an atypical case of 
aortic valve myxoma and patent foramen ovale (PFO) 
presenting with a cerebral stroke. Such cases serve to 
increase awareness of the varying presentation of aortic 
valve myxomas and highlight appropriate investigations 
and management of this condition.
Case Report
A 40-year-old male patient presented to the King 
Fahd Hospital of the University (KFHU), Khobar, Saudi 
Arabia, in 2017 with sudden-onset dysphasia, left ataxia, 
nausea and vomiting over the preceding two hours. 
The patient reported having had a previous stroke at 
the age of 11 years; however, he was unable to provide 
any information about the event. At presentation, the 
patient was alert, oriented and had stable vital signs. All 
laboratory investigation findings were within normal 
limits and electrocardiography showed normal sinus 
rhythm. As a result, the case was transferred to the stroke 
team. Urgent computed tomography (CT) of the head 
showed evidence of the prior ischaemic stroke event in 
the right occipital lobe and right cerebellum. An intra-
venous thrombolytic was administered in accordance 
with hospital guidelines. Subsequently, the patient was 
admitted to the inpatient department and received 150 mg 
of aspirin and 75 mg of clopidogrel. Symptoms improved 
over the course of the following three days. However, 
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further investigations were undertaken to determine 
the source of the stroke. 
Brain magnetic resonance imaging (MRI) revealed 
that the patient had suffered an acute ischaemic stroke, 
with a multifocal area of diffusion restriction within the 
right cerebral and superior cerebellar peduncles and both 
cerebellar hemispheres, as well as hyperintensities on 
T2-weighted fluid-attenuated inversion recovery MRI 
sequences. However, transthoracic echocardiography 
(TTE) did not show any clear source of emboli. Acc- 
ordingly, TEE was performed and revealed a small mobile 
mass measuring 6 × 2 mm attached to the right coronary 
cusp (RCC) of the aortic valve and a mobile interatrial 
septum with a small PFO visible with agitated saline 
contrast [Figure 1]. No significant arrhythmia was noted 
on a Holter monitor. A papillary fibroelastoma (PFE) 
was suspected.
After two weeks of stroke management, the decision 
was made excise the mass along with closure of the 
PFO to prevent any future embolic events. The 
surgical procedure was performed while the patient 
underwent cardiopulmonary bypass. During the 
surgery, the PFO was visible as an opening between the 
right and left atria [Figure 2]. The mass was success- 
fully excised from the RCC and the PFO was closed. 
The postoperative period was uneventful and the patient 
was discharged five days later. A histopathological exam- 
ination of the excised mass showed a paucicellular lesion 
composed of stellate and oval cells with a moderate amount 
of eosinophilic cytoplasm, fine chromatin and indistinct 
cell borders [Figure 3]. These features were consistent 
with a diagnosis of myxoma.
Discussion
To the best of the authors’ knowledge, only 11 cases 
of aortic valve myxoma have been previously reported 
in the literature [Table 1].4–14 Interestingly, nine of 
these previously reported patients were male, as in the 
current case; this is contrary to the usual female pre-
ponderance of myxoma cases.1,4–9,11,13,14 Overall, six aortic 
valve myxoma patients were symptomatic, with 
symptoms largely attributable to distal embolisation 
and ischaemia, including three cases with stroke, 
two with myocardial infarctions and one with limb 
ischaemia.4,6,8,11–13 Clinicians should therefore be aware 
of stroke as a potential presentation of aortic valve 
myxoma.
The pathogenesis of ischaemic events in aortic valve 
myxoma could be due to either embolic debris derived 
from the tumour itself or from a thrombus around the 
tumour.12 In the current case, the patient was also 
diagnosed with PFO, a potential cause of embolic stroke 
in which a paradoxical embolism may pass through a 
PFO via right-to-left shunting (RLS).15 However, in the 
current case, the observed PFO was very small in size 
and therefore would not be able to cause the RLS of 
an embolus.
 
Figure 1: Transoesophageal echocardiography of a 40- 
year-old male stroke patient in (A) bi-plane short-axis 
view showing a small mass in the right coronary cusp 
of the aortic valve measuring 3 × 5 mm and (B) three-
dimensional enfaced view showing the mass measuring 
6 × 2 mm.
 
Figure 2: Intraoperative photograph of the heart of a 
40-year-old male stroke patient showing an opening 
between the right and left atria measuring 10 × 10 mm.
 
Figure 3: Haematoxylin and eosin stains at (A) x40 magnification showing a hypocellular lesion in a myxoid matrix and 
(B) at x200 magnification showing stellate and oval cells with eosinophilic cytoplasm and indistinct cell borders.
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as filiform fronds located near valve closure lines.20 
Radiologically, TEE is superior to TTE in ident-
ifying a cardiac mass and defining its exact location, 
attachment to the underlying tissue and relation to 
surrounding structures.21,22 Among previously reported 
cases of aortic valve myxoma, 10 were identified by TTE, 
of which four were further confirmed via TEE.5–14 In 
one case, an aortic valve abnormality was first revealed 
via CT.4 In the current case, TEE revealed the mass 
to be located on the RCC of the aortic valve, thus precl-
uding a thrombus or cardiac vegetation; however, the 
preoperative diagnosis was of a PFE. As with previous 
cases, the correct diagnosis was eventually confirmed 
by histopathological examination revealing a myxoid 
matrix with ovoid myxoma cells.4–14
Typically, the management of aortic valve myxoma 
cases involves the surgical excision of the tumour as 
well as the surrounding tissue to minimise the risk of 
local recurrence, as in the present case.4,10–12 During the 
procedure, the native aortic valve should be conserved 
as much as possible; however, if the tumour is too large 
The differential diagnosis of an aortic valve myxoma
includes vegetation, a thrombus, PFE and Lambl’s excre- 
scences; these conditions can be distinguished by their 
microscopic and immunohistochemical characteristics.7,10,13 
In addition, thrombi and myxomas can be differentiated 
using two-dimensional echocardiography; the former 
typically present with a layered appearance, while an area 
of echolucency may be observed within the tumour in 
the latter.7 Moreover, vegetations of the heart valves 
are a sign of infective endocarditis; however, this was 
ruled out in the current case due to a lack of history of 
this condition.10,16 
On imaging, the size, shape, attachment site, mobility 
and location of a cardiac mass can aid in the exact 
diagnosis, along with the patient’s clinical presentation.17–19 
For example, in PFE cases, the tumour appears as a 
small mass attached to the mitral or aortic valve, usually 
located downstream and attached by a small pedicle; 
such masses are more common and often mobile and 
appear irregularly-shaped with delicate frond-like 
surfaces.7,17,18 In contrast, Lambl’s excrescences appear 
Table 1: Literature review of reported aortic valve myxoma* cases4–14




Presentation History Imaging Site Size in 
cm
Complication Surgery
Kennedy et al.8 
(1995)
23/M Leg pain None TTE RCC 
and 
LCC
1.5 Limb ischaemia AVR
Watarida et al.9 
(1997)
58/M Asymptomatic None TTE RCC 1.1 × 1 None AVR






RCC 1 Stroke AVR
Okamoto et al.10 
(2006)
61/F Endocarditis HTN 
and DM
TTE LCC 1 × 1 None Resection
Dyk et al.11 (2009) 15/M Chest pain None TTE 
and TEE
NCC 4 × 1 MI Resection
Koyalakonda et al.12 
(2011) 




RCC 1 × 1 Stroke Resection
Fernández et al.13 
(2012)
28/M Haemiparesis Epilepsy TTE RCC 
and 
LCC
1.5 × 0.7 Stroke AVR
Kim et al.7 (2012) 72/M Shortness of 
breath
HTN TTE NCC 1.5 × 0.8 None AVR






LCC 1.8 × 1.2 Acute MI CABG 
and 
resection







0.6 × 0.2 None AVR
Ji et al.14 (2017) 17/M Heart murmur None TTE NCC 2 None AVR







RCC 0.6 × 0.2 Stroke and PFO Excision 
and PFO 
closure
TTE = transthoracic echocardiography; RCC = right coronary cusp; LCC = left coronary cusp; AVR = aortic valve replacement; TEE = transoesophageal echo-
cardiography; HTN = hypertension; DM = diabetes mellitus; NCC = non-coronary cusp; MI = myocardial infarction; AF = atrial fibrillation; CKD = chronic 
kidney disease; PAD = peripheral arterial disease; CT = computed tomography; CABG = coronary artery bypass graft; PFO = patent foramen ovale. *In all 
cases, the diagnosis was confirmed via histopathological examination.
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and/or degeneration of the valvular structure occurs, 
aortic valve replacement (AVR) may be necessary. Among 
previously reported cases, seven underwent AVR, 
while resection alone was sufficient in three cases and 
one required resection and a coronary artery bypass 
graft.4–14 Nevertheless, regardless of treatment option, 
aortic valve myxoma cases require careful follow-up due 
to the high probability of local recurrence and distal 
tumour growth at the site of embolisation.5
Conclusion
An aortic valve myxoma is uncommon and may present 
with serious complications, such as stroke. In patients 
with embolic phenomena, TEE should be performed, 
with special attention to the valvular morphology. For 
valvular myxomas, aggressive surgical excision is necessary 
to prevent structural valve degeneration and local 
recurrence.
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